Abvc Biopharma (ABVC) Return on Equity [ROE] (2009 - 2026)
Abvc Biopharma (ABVC) posted Return on Equity [ROE] of -54.56% for Q3 2026, down 3.22 percentage points from -51.34% a year earlier but up 6.01 percentage points from the prior quarter.
Powered by 
Analysis
Abvc Biopharma (ABVC) Return on Equity [ROE] (2009 - 2026) Analysis & Trends
For FY2025, Abvc Biopharma's Return on Equity [ROE] came in at -119.49%, up 412.42 percentage points from FY2024.
- Annual Return on Equity [ROE] shows a five-year change of +715.56 percentage points (FY2020 to FY2025).
- In prior years, Abvc Biopharma's Return on Equity [ROE] was -531.91% in FY2024 (-163.02 pp), -368.89% in FY2023 (-99.41 pp), -269.48% in FY2022 (-60.75 pp) and -208.73% in FY2021 (+626.31 pp).
- Quarterly Return on Equity [ROE] has run from a low of -806.70% in Q2 2023 to a high of -51.34% in Q3 2025 over five years.
- On a year-over-year basis, Return on Equity [ROE] increased in five of the last eight quarters, with an average year-over-year change of +182.87 percentage points.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q4 2021, with a gain of 1240.90 percentage points; the weakest was Q2 2023, with a drop of 603.31 percentage points.
- According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -60.57% (Q2 2026), -69.84% (Q1 2026) and -60.28% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | - |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 4.66% |
| 10 | Abvc Biopharma | 24.28 Mn | 21.86 Mn | - | -54.56% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -54.56% |
| Jun 30, 2026 | -60.57% |
| Mar 31, 2026 | -69.84% |
| Dec 31, 2025 | -60.28% |
| Sep 30, 2025 | -51.34% |
| Jun 30, 2025 | -52.29% |
| Mar 31, 2025 | -75.47% |
| Dec 31, 2024 | -444.55% |
| Sep 30, 2024 | -324.49% |
| Jun 30, 2024 | -536.50% |
| Mar 31, 2024 | -686.69% |
| Dec 31, 2023 | -160.56% |
| Sep 30, 2023 | -231.81% |
| Jun 30, 2023 | -806.70% |
| Mar 31, 2023 | -487.74% |
| Dec 31, 2022 | -365.37% |
| Sep 30, 2022 | -251.62% |
| Jun 30, 2022 | -203.39% |
| Mar 31, 2022 | -208.58% |
| Dec 31, 2021 | -146.24% |
API Access
Abvc Biopharma Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();